NewsRSS

According to the report, the ministry has been holding talks on the supply of the vaccine since September 2020.

"Sinovac Biotech is China's largest vaccine manufacturer. Annually, it produces 300 to 500 million doses of vaccines that have been approved in 34 countries. The company has developed and marketed vaccines against hepatitis A and B, influenza viruses, including avian influenza, and mumps. In particular, Turkey has already made the decision to purchase Sinovac Biotech's COVID-19 vaccine in the amount of 50 million doses," the President's Office said.

According to the report, Ukraine will use the Sinovac Biotech vaccine to protect primarily those citizens who are at critical risk of infection and those who perform critical functions in the fight against the pandemic. Vaccinations will be free.

Ukrainian President Volodymyr Zelensky said the contract had been signed with an experienced vaccine manufacturer.

"The main thing is that we conducted a very active months-long negotiation work and got a concrete result. In a short time we will start a large-scale state vaccination program. We desperately need to protect the most risky social groups, and the state will definitely fulfill this task," the report reads.

The President's Office said that Sinovac Biotech's COVID-19 vaccine (CoronaVac) is an inactivated vaccine produced in ready-to-use syringes and stored at fridge temperatures of 2 to 8 degrees Celsius. Clinical trials conducted in different countries, according to interim data, showed the vaccine is up to 97% effective.

FM-TV

УСІ НОВИНИ УКРАЇНСЬКОЮ ТУТ

ВСЕ НОВОСТИ ПО-РУССКИ ЗДЕСЬ